2Majos C, Alonso J, Aguilera C. Proton magnetic resonance spectroscopy (1H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization. Eur Radiol 2003; 13:582 ~ 591
3Nicola SD, Balestr P, Dotti MT. Severe metabolite abnormalities in the white matter of patients with vacuolating megalencephalic leukoencephalopathy with subcortical cyst:a proton spectroscopic imaging study. J Neurol 2001; 248:403 ~ 409
4Mclean MA, Woermann FG, Barker GJ. Quantitative analysis of short echo time 1H - MRSI of cerebral gray and white matter. MRM 2000; 44: 401 - 411
5Nelson SJ, McKnight TR, Henry RG. Characterization of untreated gliomas by magnetic resonance spectroscopic imaging. Neuroimaging Clin N Am 2002; 12:599 - 613
6Londono A, Castillo M, Armao D.Unusual MR spectroscopic imaging pattern of an astrocytoma: lack of elevated choline and high myo- inositol and glycine levels. AJNR 2003; 24:946 - 951
7Herminghaus S, Pilatus U, Moller- Hartmann W. Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors. NMR Biomed 2002; 15: 385-392
8Hiroaki S, Toshihiro K, Reizo S. Correlation between choline level measured by proton MR spectrscopy and Ki - 67 labeling index in gliomas. AJNR 2000; 21: 659 - 665
9Castillo M.Correlation of myo- inositol levels and gradings of cerebral astrocytomas. AJNR 2000; 21:1645 - 1649
10Herholz K. In vivo 1 H imaging of glucose comsumption and lactate concentration in human gliomas. Ann Neurol 1992; 31: 319 - 322